Primary Human Cell Systems Analysis of Drug Mechanisms

BioMAP®  Systems
BioMAP® SystemsCSO and General Manager um BioSeek, LLC
Primary Human Cell Systems Analysis of Drug Mechanisms Ellen L. Berg, PhD BioSeek, Inc. SBS 15th Annual Conference Lille, France 28 April 2009 Bio Seek
Presentation Overview ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Goals for Human Cell Systems Biology Platform
BioMAP ®   Technology Platform Complementary to biochemical target and phenotypic screening  Assays Human primary cells  Disease-like culture conditions LPS BF4T SM3C Profile Database Informatics Biological responses to drugs and stored in the database Specialized informatics tools are used to mine and analyze biological data
[object Object],[object Object],[object Object],[object Object],[object Object],BioMAP ®   Technology Platform Assays Human primary cells  Disease-like culture conditions >25 BioMAP Systems ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],LPS BF4T SM3C
Assays Human primary cells  Disease-like culture conditions Profile Database Biological responses to drugs and stored in the database BioMAP ®   Technology Platform ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],LPS BF4T SM3C
Assays are Robust and Highly Reproducible  High Correlation of Experimental Replicates 5   M dose Pearson Correlation Coefficient Consistent data experiment-to-experiment  Pearson correlation >0.8 (perfect match = 1)
Microtubule Stabilizers Mitochondrial  ET chain Retinoids Hsp90 CDK NF  B MEK DNA synthesis JNK Protein synthesis Microtubule Destabilizers Estrogen R PI-3K Ca ++ Mobilization Classification of Drugs By Mechanism  Pairwise Correlation of BioMAP Reveals Functional Similarities  mTOR PKC Activation p38 MAPK HMG-CoA reductase Calcineurin Transcription
BioMAP Systems are Validated   Corticosteroids (Prednisolone) Are Active in Inflammation Systems Profiles retain shape over multiple concentrations BioMAP Systems Readout Parameters (Biomarkers) Cytotoxicity Readouts Log expression ratio (Drug/DMSO control) Control (no drug) 99% significance  envelope Dose Response
E-selectin TNF-  IL-8 BioMAP Systems are Validated  Activities of Corticosteroids Match Clinical Effects PGE 2 IL-8 MCP-1 Readouts in BioMAP show the same pattern as has been reported for patients receiving steroid therapy  Log expression ratio (Drug/DMSO control) MCP-1, IL-8, E-sel. decrease Leukocyte recruitment Many, e.g. Jilma et al., 2000 PGE 2  decrease Pain, swelling Sebaldt et al., 1990 Collagen I & III Collagen I, III decrease Skin atrophy Autio et al., 1994 MMP-1 PAI-1 SAA PAI-1, SAA increase CV complications Sartori et al., 1999 Fyfe et al., 1997 PAI-1
Project Goal ,[object Object],[object Object],[object Object],[object Object],PPAR  PPAR  Rosiglitazone (Avandia) Troglitazone (Resulin) Pioglitazone (Actos) Fenofibrate (Tricor)
BioMAP Profile of Rosiglitazone Eot3 IP-10 I-TAC VCAM E-sel Monocyte activation Macrophage activation T cell  activation MCP-1 TNF  MCSF CD40 IL-8 IP-10 I-TAC ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BioMAP Systems
BioMAP Profile of Rosiglitazone Eot3 IP-10 I-TAC MMP9 VCAM E-sel Monocyte activation Macrophage activation T cell  activation MCP-1 TNF  MCSF CD40 IL-8 uPAR Col III Col IV PAI-1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Col III BioMAP Systems
BioMAP Profile of Rosiglitazone ,[object Object],[object Object],[object Object],PGJ2 PGF1a PGD2 PGF2a PGD2 PGF2a PGJ2 PGF1a PGJ2 PG1a PGE2 PGD2 PGF2a PGF2a Leukocyte-containing systems Bronchial epithelial cell-containing systems BioMAP Systems
Upregulation of Prostaglandins by Rosiglitazone ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Rosiglitazone Upregulation of PGE2 is not a Class Effect Search of BioMAP Database for Compounds that Increase PGE2 Retinoids Microtubule Destabilizers TXA2 inhibitor PPAR  PPAR  RNA Synthesis Inhibitor mTOR Inhibitor AMPK activator JNK Inhibitor CYP450 Inhibitor Compound Specific Effect Mechanism Class Effect
BioMAP Profile of Pioglitazone MMP9 IL-8 Monocyte activation MCSF CD40 ITAC MCP-1 CD38 T cell  activation PGJ2 PGD2 PGF2a PGJ2 PGD2 PGE2 PGF2a PGJ2 PGD2 PGF2a PGF1a PGJ2 PGD2 PGF2a PGF1a VCAM CD40 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
BioMAP Profile of Troglitazone Eot3 IP-10 I-TAC MMP9 E-sel Monocyte activation Macrophage activation T cell  activation TNF  uPAR MCP-1 TF Col III Col IV MMP1 TM MCP-1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],PGF1a PGD2 PGF2a PGF1a PGD2 PGF2a
BioMAP Profile of Fenofibrate - PPAR  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Eot3 IL-8 MMP9 Monocyte activation T cell  activation MCSF CD69 uPAR HLA-DR TM Col III MMP1 IL-8 MCP-1 PGJ2 PGD2 PGF2a PGJ2 PGD2 PGF2a PGD2 PGE2 PGF2a PGF1a PGJ2 PGD2 PGF2a PGF1a Mig VCAM ITAC VCAM IL1  IL-8 TM
Summary of PPAR Agonists ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Summary ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Acknowledgements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
1 von 23

Recomendados

mTOR: growth regulator involved in disease von
mTOR: growth regulator involved in diseasemTOR: growth regulator involved in disease
mTOR: growth regulator involved in diseasedgotto
4.5K views26 Folien
Metabolic investigation of segmental overgrowth: new insights in pathogenic m... von
Metabolic investigation of segmental overgrowth: new insights in pathogenic m...Metabolic investigation of segmental overgrowth: new insights in pathogenic m...
Metabolic investigation of segmental overgrowth: new insights in pathogenic m...BiologInc
185 views28 Folien
Inhibition of the mtorc pathway in the antiphospholipid von
Inhibition of the mtorc pathway in the antiphospholipidInhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipidSaris Arango
849 views23 Folien
mTOR inhibitor in cancer von
mTOR inhibitor in cancermTOR inhibitor in cancer
mTOR inhibitor in cancerseayat1103
5.9K views32 Folien
The mammalian target of rapamycin a cell key modulator of ageing von
The mammalian target of rapamycin a cell key modulator of ageingThe mammalian target of rapamycin a cell key modulator of ageing
The mammalian target of rapamycin a cell key modulator of ageingXavier Viñals Gonzalez
497 views8 Folien
Anti-cancer as Protein kinase C & tyrosine inhibitor. von
Anti-cancer as Protein kinase C & tyrosine inhibitor.Anti-cancer as Protein kinase C & tyrosine inhibitor.
Anti-cancer as Protein kinase C & tyrosine inhibitor.Omer Bayazeid, PhD
3.9K views26 Folien

Más contenido relacionado

Was ist angesagt?

Tyrosinekinase inhibitors rahul von
Tyrosinekinase inhibitors  rahulTyrosinekinase inhibitors  rahul
Tyrosinekinase inhibitors rahulRahul Sankar
953 views25 Folien
Important inhibitors of protein synthesis von
Important inhibitors of protein synthesisImportant inhibitors of protein synthesis
Important inhibitors of protein synthesisEmaSushan
503 views5 Folien
Receptor Tyrosine Kinases von
Receptor Tyrosine KinasesReceptor Tyrosine Kinases
Receptor Tyrosine Kinasesfondas vakalis
7.3K views43 Folien
Tyrosine kinase report von
Tyrosine kinase reportTyrosine kinase report
Tyrosine kinase reportjinx11
4.4K views31 Folien
Cancer signal-transduction von
Cancer signal-transductionCancer signal-transduction
Cancer signal-transductionDeepika Tripathi
15.1K views52 Folien
Regulation of Glycolysis downstream of mTOR von
Regulation of Glycolysis downstream of mTORRegulation of Glycolysis downstream of mTOR
Regulation of Glycolysis downstream of mTOReadvisor
2.5K views19 Folien

Was ist angesagt?(20)

Tyrosinekinase inhibitors rahul von Rahul Sankar
Tyrosinekinase inhibitors  rahulTyrosinekinase inhibitors  rahul
Tyrosinekinase inhibitors rahul
Rahul Sankar953 views
Important inhibitors of protein synthesis von EmaSushan
Important inhibitors of protein synthesisImportant inhibitors of protein synthesis
Important inhibitors of protein synthesis
EmaSushan503 views
Tyrosine kinase report von jinx11
Tyrosine kinase reportTyrosine kinase report
Tyrosine kinase report
jinx114.4K views
Regulation of Glycolysis downstream of mTOR von eadvisor
Regulation of Glycolysis downstream of mTORRegulation of Glycolysis downstream of mTOR
Regulation of Glycolysis downstream of mTOR
eadvisor2.5K views
Proteomics of Hormone Fragments 111112 von Roshan Kumar
Proteomics of Hormone Fragments 111112Proteomics of Hormone Fragments 111112
Proteomics of Hormone Fragments 111112
Roshan Kumar178 views
Molecular mechanisms final von mosaiques
Molecular mechanisms finalMolecular mechanisms final
Molecular mechanisms final
mosaiques2K views
epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF... von Bholakant raut
epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...
epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...
Bholakant raut4.4K views
Novel Tyrosine Kinase Inhibitors for Ovarian Cancer von Zuleika86
Novel Tyrosine Kinase Inhibitors for Ovarian CancerNovel Tyrosine Kinase Inhibitors for Ovarian Cancer
Novel Tyrosine Kinase Inhibitors for Ovarian Cancer
Zuleika861.3K views
Epidermal growth factor and its receptor tyrosine kinase von Gedion Yilma
Epidermal growth factor and its receptor tyrosine kinaseEpidermal growth factor and its receptor tyrosine kinase
Epidermal growth factor and its receptor tyrosine kinase
Gedion Yilma2.9K views
gonadocorticoids: a potential treatment for parkinson's disease von SurbhiPanwar5
gonadocorticoids: a potential treatment for parkinson's diseasegonadocorticoids: a potential treatment for parkinson's disease
gonadocorticoids: a potential treatment for parkinson's disease
SurbhiPanwar593 views
Polymorphism affecting drug metabolism . von heenakazi4
Polymorphism affecting drug metabolism .Polymorphism affecting drug metabolism .
Polymorphism affecting drug metabolism .
heenakazi41.6K views
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa... von bioejjournal
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...
Cloning and Extracellular Expression of Recombinant Tissue Plasminogen Activa...
bioejjournal42 views
Cloning and extracellular expression of recombinant tissue plasminogen activa... von bioejjournal
Cloning and extracellular expression of recombinant tissue plasminogen activa...Cloning and extracellular expression of recombinant tissue plasminogen activa...
Cloning and extracellular expression of recombinant tissue plasminogen activa...
bioejjournal60 views
Ardi - Tsri 2008 von vcardi
Ardi - Tsri 2008Ardi - Tsri 2008
Ardi - Tsri 2008
vcardi664 views

Similar a Primary Human Cell Systems Analysis of Drug Mechanisms

BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery von
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug DiscoveryBioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug DiscoveryBioMAP® Systems
718 views38 Folien
PINK1 Genetic Paper von
PINK1 Genetic PaperPINK1 Genetic Paper
PINK1 Genetic PaperMichelle Bojorquez
2 views79 Folien
Biochemistry of hormones von
Biochemistry of hormonesBiochemistry of hormones
Biochemistry of hormonesZagazig University
54 views83 Folien
Panitumumab (vectibix) von
Panitumumab (vectibix)Panitumumab (vectibix)
Panitumumab (vectibix)Vibhay Pareek
2.1K views36 Folien
P glycoprotein von
P glycoprotein P glycoprotein
P glycoprotein khaterehz
1.1K views23 Folien
Insulin resistance 2013 von
Insulin resistance 2013Insulin resistance 2013
Insulin resistance 2013Elsa von Licy
1.5K views26 Folien

Similar a Primary Human Cell Systems Analysis of Drug Mechanisms(20)

BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery von BioMAP® Systems
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug DiscoveryBioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP<sup>®</sup> Primary Human Cell-Based Systems for Drug Discovery
BioMAP® Systems718 views
P glycoprotein von khaterehz
P glycoprotein P glycoprotein
P glycoprotein
khaterehz1.1K views
Insulin resistance 2013 von Elsa von Licy
Insulin resistance 2013Insulin resistance 2013
Insulin resistance 2013
Elsa von Licy1.5K views
The PTEN and PI3-Kinase Pathway in Cancer ppt von Bernard Bahaah
The PTEN and PI3-Kinase Pathway in Cancer pptThe PTEN and PI3-Kinase Pathway in Cancer ppt
The PTEN and PI3-Kinase Pathway in Cancer ppt
Bernard Bahaah3.3K views
Future trends and perspectives in modern pharmaceutical biotechnology von inemet
Future trends and perspectives in modern pharmaceutical biotechnologyFuture trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnology
inemet8K views
Enabling Cancer Immunotherapy: From Discovery to Combinations von DiscoverX Corporation
Enabling Cancer Immunotherapy: From Discovery to CombinationsEnabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to Combinations
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi... von BioMAP® Systems
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...
Selection of Safer and More Effective Anti-inflammatory Kinase Inhibitors usi...
BioMAP® Systems7K views
From Nutrigenomics to nutritional systems biology of fatty acid sensing von Norwich Research Park
From Nutrigenomics to nutritional systems biology of fatty acid sensingFrom Nutrigenomics to nutritional systems biology of fatty acid sensing
From Nutrigenomics to nutritional systems biology of fatty acid sensing
Investigation of Intracellular Signal Transduction in Multiple Endocrine Neop... von KayvonneFerguson
Investigation of Intracellular Signal Transduction in Multiple Endocrine Neop...Investigation of Intracellular Signal Transduction in Multiple Endocrine Neop...
Investigation of Intracellular Signal Transduction in Multiple Endocrine Neop...
KayvonneFerguson20 views
Predictive Models for Mechanism of Action Classification from Phenotypic Assa... von Ellen Berg
Predictive Models for Mechanism of Action Classification from Phenotypic Assa...Predictive Models for Mechanism of Action Classification from Phenotypic Assa...
Predictive Models for Mechanism of Action Classification from Phenotypic Assa...
Ellen Berg842 views
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C... von BioMAP® Systems
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
BioMAP® Systems664 views
Stat3 &other target proteins in psoriasis by yousry a mawla von M.YOUSRY Abdel-Mawla
Stat3 &other target  proteins    in  psoriasis by yousry a mawlaStat3 &other target  proteins    in  psoriasis by yousry a mawla
Stat3 &other target proteins in psoriasis by yousry a mawla

Más de BioMAP® Systems

BioSeek Presentation at the 2012 Inflammation Res Assoc. Conference von
BioSeek Presentation at the 2012 Inflammation Res Assoc. ConferenceBioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek Presentation at the 2012 Inflammation Res Assoc. ConferenceBioMAP® Systems
9.1K views39 Folien
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C... von
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...BioMAP® Systems
5.9K views30 Folien
Primary Human Cell Systems Analysis of Drug Mechanisms von
Primary Human Cell Systems Analysis of Drug MechanismsPrimary Human Cell Systems Analysis of Drug Mechanisms
Primary Human Cell Systems Analysis of Drug MechanismsBioMAP® Systems
5.7K views23 Folien
BioSeek EPA ToxCast Program von
BioSeek EPA ToxCast ProgramBioSeek EPA ToxCast Program
BioSeek EPA ToxCast ProgramBioMAP® Systems
6.2K views13 Folien
Diversity Plus Panel of BioMAP<sup>®</sup> Systems von
Diversity Plus Panel of BioMAP<sup>®</sup> SystemsDiversity Plus Panel of BioMAP<sup>®</sup> Systems
Diversity Plus Panel of BioMAP<sup>®</sup> SystemsBioMAP® Systems
6.3K views8 Folien
Introduction to BioMAP<sup>®</sup> Systems von
Introduction to BioMAP<sup>®</sup> SystemsIntroduction to BioMAP<sup>®</sup> Systems
Introduction to BioMAP<sup>®</sup> SystemsBioMAP® Systems
6.7K views13 Folien

Más de BioMAP® Systems(7)

BioSeek Presentation at the 2012 Inflammation Res Assoc. Conference von BioMAP® Systems
BioSeek Presentation at the 2012 Inflammation Res Assoc. ConferenceBioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioSeek Presentation at the 2012 Inflammation Res Assoc. Conference
BioMAP® Systems9.1K views
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C... von BioMAP® Systems
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
Defining Chemical Target and Pathway Toxicity Mechanisms with Primary Human C...
BioMAP® Systems5.9K views
Primary Human Cell Systems Analysis of Drug Mechanisms von BioMAP® Systems
Primary Human Cell Systems Analysis of Drug MechanismsPrimary Human Cell Systems Analysis of Drug Mechanisms
Primary Human Cell Systems Analysis of Drug Mechanisms
BioMAP® Systems5.7K views
Diversity Plus Panel of BioMAP<sup>®</sup> Systems von BioMAP® Systems
Diversity Plus Panel of BioMAP<sup>®</sup> SystemsDiversity Plus Panel of BioMAP<sup>®</sup> Systems
Diversity Plus Panel of BioMAP<sup>®</sup> Systems
BioMAP® Systems6.3K views
Introduction to BioMAP<sup>®</sup> Systems von BioMAP® Systems
Introduction to BioMAP<sup>®</sup> SystemsIntroduction to BioMAP<sup>®</sup> Systems
Introduction to BioMAP<sup>®</sup> Systems
BioMAP® Systems6.7K views
Methods and Approaches for Defining Mechanism Signatures from Human Primary C... von BioMAP® Systems
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
Methods and Approaches for Defining Mechanism Signatures from Human Primary C...
BioMAP® Systems318 views

Primary Human Cell Systems Analysis of Drug Mechanisms

  • 1. Primary Human Cell Systems Analysis of Drug Mechanisms Ellen L. Berg, PhD BioSeek, Inc. SBS 15th Annual Conference Lille, France 28 April 2009 Bio Seek
  • 2.
  • 3.
  • 4. BioMAP ® Technology Platform Complementary to biochemical target and phenotypic screening Assays Human primary cells Disease-like culture conditions LPS BF4T SM3C Profile Database Informatics Biological responses to drugs and stored in the database Specialized informatics tools are used to mine and analyze biological data
  • 5.
  • 6.
  • 7. Assays are Robust and Highly Reproducible High Correlation of Experimental Replicates 5  M dose Pearson Correlation Coefficient Consistent data experiment-to-experiment Pearson correlation >0.8 (perfect match = 1)
  • 8. Microtubule Stabilizers Mitochondrial ET chain Retinoids Hsp90 CDK NF  B MEK DNA synthesis JNK Protein synthesis Microtubule Destabilizers Estrogen R PI-3K Ca ++ Mobilization Classification of Drugs By Mechanism Pairwise Correlation of BioMAP Reveals Functional Similarities mTOR PKC Activation p38 MAPK HMG-CoA reductase Calcineurin Transcription
  • 9. BioMAP Systems are Validated Corticosteroids (Prednisolone) Are Active in Inflammation Systems Profiles retain shape over multiple concentrations BioMAP Systems Readout Parameters (Biomarkers) Cytotoxicity Readouts Log expression ratio (Drug/DMSO control) Control (no drug) 99% significance envelope Dose Response
  • 10. E-selectin TNF-  IL-8 BioMAP Systems are Validated Activities of Corticosteroids Match Clinical Effects PGE 2 IL-8 MCP-1 Readouts in BioMAP show the same pattern as has been reported for patients receiving steroid therapy Log expression ratio (Drug/DMSO control) MCP-1, IL-8, E-sel. decrease Leukocyte recruitment Many, e.g. Jilma et al., 2000 PGE 2 decrease Pain, swelling Sebaldt et al., 1990 Collagen I & III Collagen I, III decrease Skin atrophy Autio et al., 1994 MMP-1 PAI-1 SAA PAI-1, SAA increase CV complications Sartori et al., 1999 Fyfe et al., 1997 PAI-1
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16. Rosiglitazone Upregulation of PGE2 is not a Class Effect Search of BioMAP Database for Compounds that Increase PGE2 Retinoids Microtubule Destabilizers TXA2 inhibitor PPAR  PPAR  RNA Synthesis Inhibitor mTOR Inhibitor AMPK activator JNK Inhibitor CYP450 Inhibitor Compound Specific Effect Mechanism Class Effect
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.  

Hinweis der Redaktion

  1. 2 1
  2. BioMAP systems are complex primary human cell based disease models that can be used directly for phenotypic screening. The most attractive feature of this platform, however, is it’s ability of the platform to provide target and pathway mechanisms of action. This enables reverse pharmacology of bioactive agents and drugs as well as in depth characterization of leads for identifying on versus off-target biology, which in turn impact safety and also clinical indication selection.